Biotechnology News

September 4, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today introduced SureGuide, the first in a new series of kits to advance genome editing and synthetic biology. The complete SureGuide workflow includes a SureGuide Cas9...

September 4, 2014

ZUG, Switzerland--(BUSINESS WIRE)--PSI CRO, a global full-service contract research organization, are further strengthening their clinical trial management approaches in the area of Infectious Diseases.

September 4, 2014

BOSTON & GENEVA--(BUSINESS WIRE)--Dr. Susan Dallabrida, VP at patient-driven eData innovator PHT Corp., will present a poster, Effective Use of Electronic Patient Reported Outcomes (ePRO) in Multiple Myeloma at the ESMO 2014 Congress.

September 4, 2014

SAN ANTONIO--(BUSINESS WIRE)--DPT Laboratories, a contract development and manufacturing organization (CDMO), announces the acquisition of Meda Pharmaceuticals' Lakewood, New Jersey, facilities.

September 4, 2014

MADISON, Wis.--(BUSINESS WIRE)--The 25th International Symposium on Human Identification (ISHI) 2014 will be held September 29–October 2 at the Arizona Biltmore, 2400 East Missouri Avenue, Phoenix, Arizona.

September 4, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced that Peter D. Suzdak, PhD, the Company’s...

September 4, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck’s Investigational Beta-lactamase Inhibitor Relebactam (MK-7655) Granted Qualified Infectious Disease Product (QIDP) and Fast Track Designations by FDA

September 4, 2014

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®; NYSE: LH) announced today the launch of Enlighten Health Genomics, a new business that builds on the diagnostic potential of Next-Generation Sequencing (NGS...

September 4, 2014

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ:CERS) announced today that William “Obi” Greenman, president and chief executive officer, is scheduled to present a corporate update at the Morgan Stanley 2014 Global Health Care...

September 4, 2014

NORTH HOLLYWOOD, Calif.--(BUSINESS WIRE)--The IMF says data in the New England Journal of Medicine confirm REVLIMID plus low-dose dexamethasone improves survival in newly diagnosed myeloma patients not eligible for a stem cell transplant.

September 4, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tricida announces discovery of a clinical candidate for treatment of complications of cardiorenal disease; $10 million Series A financing by OrbiMed, Sibling Capital and Limulus Venture Partners.

September 4, 2014

EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed, Inc. has received a U.S. patent allowance for noscapine, which covers the treatment of ALS, Parkinson's disease, and diabetic neuropathy.

September 4, 2014

AUSTIN, Texas & BELFAST, United Kingdom--(BUSINESS WIRE)--Asuragen, a molecular diagnostics company using genomics to drive better patient management, and Labceutics, the leading global personalized medicine laboratory network, announced...

September 4, 2014

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus released preliminary revenues for its 4th fiscal quarter of FY2014. Revenues increased 15.1%, to $1.805 million, over 4QFY13. For FY2014, preliminary revenues were up 11.9% over FY13.

September 4, 2014

VICTORIA, British Columbia--(BUSINESS WIRE)--GenoLogics today announced it has been selected by Illumina as the preferred laboratory information management system (LIMS) provider to support HiSeq X Ten sequencing system customers.

September 4, 2014

YOKNEAM, Israel--(BUSINESS WIRE)--EndoCross receives CE Mark on the ENABLER-C Coronary Catheter System for the treatment of Coronary Chronic Total Occlusions (CTO).

September 4, 2014

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announces the launch of the generic equivalent to Baraclude® (Entecavir) Tablets, 0.5mg and 1mg, in the United States. Teva was first to file, making the product...

September 4, 2014

TOULOUSE, France--(BUSINESS WIRE)--GamaMabs Pharma announces two scientific communications on its AMHR2 project.

September 4, 2014

MONTCLAIR, N.J.--(BUSINESS WIRE)--MetaStat's CEO, Dr. Oscar Bronsther, M.D., will be speaking at the Aegis Capital Conference on September 11 at 3:30 PM Pacific Time. He will provide an overview of the company.

September 4, 2014

ALPHARETTA, Ga.--(BUSINESS WIRE)--Clearside Biomedical Inc. announces the U.S. Patent and Trademark Office granted the company its fourth patent allowance related to its proprietary microneedle drug delivery methods and devices.

September 4, 2014

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea signs a development and commercialization agreement for Lymphoseek with Hainan Sinotau Pharmaceutical aimed at gaining regulatory approval with China FDA and sales in China.

September 4, 2014

BASEL, Switzerland--(BUSINESS WIRE)--"In my 30 years of business I have not experienced such enthusiasm and commitment from a prospective partner to support and drive a process - not with aggression but with patience and competence."

September 4, 2014

SUMMIT, N.J.--(BUSINESS WIRE)--Phase III study of continuous REVLIMID and dexamethasone published in New England Journal of Medicine.

September 4, 2014

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that Michael Rogers, Acorda’s Chief Financial Officer, will present at the Aegis Capital 2014 Healthcare and Technology Conference. The conference will take...

September 4, 2014

HAYWARD, Calif.--(BUSINESS WIRE)--FDA has granted Fast Track designation to Aradigm's lead product candidate, Pulmaquin, for non-cystic fibrosis bronchiectasis.

September 4, 2014

CHICAGO--(BUSINESS WIRE)--RestorGenex Corporation (OTCQB: RESX), a specialty biopharmaceutical company initially focused on developing products for dermatology, ophthalmology and women’s health, today announced that Stephen M. Simes, RestorGenex’...

September 4, 2014

RICHMOND, Va.--(BUSINESS WIRE)--AmpliPhi to present Next Generation Antibacterial Agents with in vitro efficacy to kill multi drug resistant bacteria; MRSA, VRSA

September 4, 2014

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Global Genes™ announced today platinum recording artist Kris Allen, best known for winning season eight of ‘American Idol’; singer/songwriter Jessi Malay; and dance team Culture Shock LA will perform.

September 4, 2014

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces results from the complete analysis of the European Phase 2/3 clinical study of its...

September 4, 2014

PARIS--(BUSINESS WIRE)--Cellectis announces the closing of the sale of its Swedish subsidiary Cellectis AB to Takara Bio Inc.

September 4, 2014

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ: CLVS) announced today the pricing of $250 million aggregate principal amount of its 2.50% convertible senior notes due 2021 in a private placement to qualified institutional buyers...

September 3, 2014

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion announced that NICE has issued a recommendation that eculizumab (Soliris®) be nationally commissioned for all patients suffering from atypical hemolytic uremic syndrome.

September 3, 2014

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that Paul Berns, the company’s President and Chief Executive Officer, will provide a company overview at the Morgan Stanley Global Healthcare...

September 3, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from two upcoming investor conferences: the Robert W. Baird & Co. 2014 Health Care Conference and the...

September 3, 2014

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, will announce the final results from its European Phase 2/3 clinical trial of its proprietary...

September 3, 2014

BLUE BELL, Pa.--(BUSINESS WIRE)--Wingspan Technology released a new version of its eTMF, featuring integrated scanning capabilities which eliminate the need for manual upload or indexing of TMF documents.

September 3, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Morgan Stanley Global Healthcare Conference on Wednesday, September 10, 2014 at 8:00 a.m. Eastern Time at the Grand Hyatt New...

September 3, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Morgan Stanley Global Healthcare Conference on Wednesday...

September 3, 2014

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS Reaches 10,000 Self-Apposing Stent implantations.

September 3, 2014

BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix To Present At Morgan Stanley 2014 Global Healthcare Conference

September 3, 2014

SAN ANTONIO--(BUSINESS WIRE)--CeloNova BioSciences today announced U.S. FDA 510(k) clearance expanding the indication for their innovative Oncozene® and Embozene® microsphere products to now include the embolization of Hepatoma.

September 3, 2014

CAPE TOWN, South Africa--(BUSINESS WIRE)--South African Orthopaedic Association Congress, Cape Town – Data presented this week from a recently completed clinical trial with the REPAIR™ Bone Putty show the blood plasma-based Putty reduced...

September 3, 2014

WASHINGTON--(BUSINESS WIRE)--SDSU, the South Dakota Biotech Association and select Brookings firms will provide attendees of the upcoming 2014 BIO Livestock Biotech Summit the opportunity to tour the campus and select facilities.

September 3, 2014

BOSTON--(BUSINESS WIRE)--Best Doctors, Inc. acquires Rise Health to accelerate expansion of its digital health solutions focused on helping people get the right diagnosis and treatment

September 3, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Geno Germano, Group President, Global Innovative Pharma Business, at the Morgan Stanley Global Healthcare Conference on...

September 3, 2014

MUNICH--(BUSINESS WIRE)--Definiens, the global leader in Tissue Phenomics™ for oncology diagnostics, announced that registration is now open for The International Symposium for Tissue Phenomics, October 17-18 in San Francisco

September 3, 2014

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD has acquired RCT Logic’s exclusive license from Massachusetts General Hospital (MGH) for the portfolio of patents related to its sequential parallel comparison design (SPCD).

September 3, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced it has received a notice of allowance...